NCT07164209Completed
The Remeasure Trial
Resection of the Mesentery With Functional End-to-end Anastomosis vs Kono Anastomosis in Preventing Relapse After Ileocolic Resection for Primary Crohn Disease: a Prospective, Randomized, Controlled Trial Remeasure CD TRial
Source: ClinicalTrials.gov · Last updated 8 Oct 2025
Brief summary (registry, in English)
Aim of the present study is to compare a stapled, functional end-to-end, ileo-colic anastomosis with removal of the mesentery vs the manual, functional end-to-end, ileo-colic Kono-S anastomosis with mesentery preservation, in terms of peri-operative safety, and efficacy in preventing endoscopic recurrence after ileocolic resection for Crohn Disease. Patients presenting with ileocolic primary Crohn disease either not suitable for medical treatment or with contraindications for therapy i.e: occlusion, abscess, contraindications to the use of biologics
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 73 (actual)
- First submitted
- 2 Sept 2025
- Start date
- Jan 2022
- Primary completion date
- Dec 2024
- Lead sponsor
- Azienda Ospedaliera Ordine Mauriziano di Torino
- Diseases
- Crohn's disease
- NCT number
- NCT07164209
What you commit to
- Study type: Interventional
- Participants enrolled: 73
- From Jan 2022 to the primary completion date, Dec 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Older than 70
- Recurrent disease, previous surgery for CD
- Gastroenterologists or patients not willing to maintain a drug washout for six months
- Emergency surgery
Who the study is looking for
- • Patients \> 18 years
- Histological diagnosis of Crohn's Disease
- Patient's ability to read and understand the documentation concerning the study and the Informed consent
- Ileocolic disease requiring resection
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Dott Lucia Borsotti is the head of the experimetal Office in Azienda Sanitaria Ospedaliera Ordine Mauriziano and could answer about enrolling of patients and submission of the protocol to the ethicl Commette of Città della Salute e della Scienza of Torin Coordinator of this site? Confirm its status | Torino | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.